About COEUS
COEUS is a Healthcare company based in Devon (United States) founded in 2009, and was acquired by Red Nucleus in February 2025. Provider of formulations development and consulting services for biopharma sector. COEUS offers products and services including COEBRA Platform. Its focus areas include Biopharma Outsourcing, Diversified and Small Molecules & Peptides. Its competitors include Pfizer, LabConnect and Ainos; 2 of its 3 listed competitors have raised funding.
Company details
COEUS, based in Devon, focuses on providing healthcare solutions, biopharma outsourcing, diversified, and small molecules peptides. Provider of formulations development and consulting services for biopharma sector. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Devon, United States
- Stage Acquired
- SectorsHealthcare
- Website 1coeus.com
- Social LinkedIn X
- Acquired by Red Nucleus (Feb 2025)
- Investors
- Acquired byRed Nucleus
(Feb 2025)
Products & Services of COEUS
COEUS offers a comprehensive portfolio of products and services, including COEBRA Platform.
Manages value-based health contracts and outcomes in pharmaceuticals
Investors in COEUS
COEUS has secured backing from 1 investor. Prominent investors backing the company include Red Nucleus.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Advisory, scientific, and medical communications provided for pharmaceutical industry. | 2014 | rednucleus.com | Yardley, United States |
Investor details for COEUS
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of COEUS
2 dated milestones of COEUS across 16 years, from founding to its latest funding, stage changes and deals.
- Founded COEUS is founded.
- Exit Acquired by Red Nucleus.
Competitors of COEUS
COEUS has 3 listed competitors in our database, 2 of them funded. They include Pfizer, LabConnect and Ainos.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pfizer.com | 1849 | New York, United States | $8M | Pharmaceutical products for treating multiple diseases are provided. | ||
| labconnect.com | 2002 | Johnson, United States | $28.5M | Laboratory testing, clinical trial research, and biopharma services are provided. | ||
| ainos.com | 1986 | San Diego, United States | 43 | Novel point-of-care testing and low-dose interferon therapeutics are developed. |
Detailed competitors of COEUS
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of COEUS
The website of COEUS (1coeus.com) receives about 1.7K visits a month.
- Monthly visits1.7K
▼ 10% vs previous month
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as COEUS (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about COEUS
COEUS was founded in 2009.
COEUS is headquartered in Devon, United States. It is registered at Devon, Pennsylvania, United States.
COEUS, based in Devon, focuses on providing healthcare solutions, biopharma outsourcing, diversified, and small molecules peptides. Provider of formulations development and consulting services for biopharma sector. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
COEUS's top competitors include Pfizer, LabConnect and Ainos.
COEUS offers COEBRA Platform.
COEUS has 1 investor. Key investors include Red Nucleus.
Yes. COEUS was acquired by Red Nucleus in February 2025.